Indoco Remedies Limited
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more
Indoco Remedies Limited (INDOCO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.162x
Based on the latest financial reports, Indoco Remedies Limited (INDOCO) has a cash flow conversion efficiency ratio of 0.162x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹1.58 Billion) by net assets (₹9.74 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Indoco Remedies Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Indoco Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Indoco Remedies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Indoco Remedies Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FOCUSRITE PLC LS -001
F:0FO
|
N/A |
|
Forest Water Environmental Eng Co Ltd
TW:8473
|
0.072x |
|
Eliem Therapeutics Inc
NASDAQ:ELYM
|
-0.003x |
|
Emerging Display Technologies Corp
TW:3038
|
0.078x |
|
Amulaire Thermal Technology
TW:2241
|
-0.032x |
|
Havilah Resources Ltd
AU:HAV
|
-0.010x |
|
Central Omega Resources Tbk PT
JK:DKFT
|
0.283x |
|
Radisson Mining Resources Inc
OTCQB:RMRDF
|
0.013x |
Annual Cash Flow Conversion Efficiency for Indoco Remedies Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Indoco Remedies Limited from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹10.18 Billion | ₹278.90 Million | 0.027x | -80.43% |
| 2024-03-31 | ₹11.10 Billion | ₹1.55 Billion | 0.140x | -19.54% |
| 2023-03-31 | ₹10.28 Billion | ₹1.79 Billion | 0.174x | -9.50% |
| 2022-03-31 | ₹9.05 Billion | ₹1.74 Billion | 0.192x | +79.71% |
| 2021-03-31 | ₹7.69 Billion | ₹822.22 Million | 0.107x | -40.85% |
| 2020-03-31 | ₹6.80 Billion | ₹1.23 Billion | 0.181x | -9.61% |
| 2019-03-31 | ₹6.61 Billion | ₹1.32 Billion | 0.200x | +10.00% |
| 2018-03-31 | ₹6.75 Billion | ₹1.23 Billion | 0.182x | +33.64% |
| 2017-03-31 | ₹6.52 Billion | ₹886.40 Million | 0.136x | -29.86% |
| 2016-03-31 | ₹5.84 Billion | ₹1.13 Billion | 0.194x | -8.10% |
| 2015-03-31 | ₹5.19 Billion | ₹1.09 Billion | 0.211x | -2.30% |
| 2014-03-31 | ₹4.57 Billion | ₹988.09 Million | 0.216x | +29.87% |
| 2013-03-31 | ₹4.14 Billion | ₹688.69 Million | 0.166x | +8.53% |
| 2012-03-31 | ₹3.85 Billion | ₹589.71 Million | 0.153x | +27.38% |
| 2011-03-31 | ₹3.50 Billion | ₹421.36 Million | 0.120x | -21.91% |
| 2010-03-31 | ₹3.11 Billion | ₹478.40 Million | 0.154x | +13.60% |
| 2009-03-31 | ₹2.78 Billion | ₹377.64 Million | 0.136x | +30.76% |
| 2008-03-31 | ₹2.54 Billion | ₹263.71 Million | 0.104x | +185.15% |
| 2007-03-31 | ₹2.33 Billion | ₹84.76 Million | 0.036x | -80.49% |
| 2006-03-31 | ₹1.98 Billion | ₹369.86 Million | 0.186x | +438.09% |
| 2005-03-31 | ₹1.75 Billion | ₹60.74 Million | 0.035x | -81.85% |
| 2004-03-31 | ₹880.11 Million | ₹168.02 Million | 0.191x | -- |